{"symbol":"BSX","fiscalQuarter":"Q4-2016","reportDate":"2017-02-02","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2016","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 4.76%","keyNumbers":[{"metric":"EPS","actual":"$0.30","expected":"N/A","surprise":"+4.90%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed satisfaction with the EPS performance despite not providing revenue figures.","They highlighted ongoing efforts to improve operational efficiency."],"summary":"Overall, management conveyed a sense of cautious optimism regarding the company's performance. They emphasized their commitment to enhancing operational efficiency."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a positive surprise in EPS, which likely contributed to the stock's 4.76% increase. The lack of revenue details may leave some investors wanting more information, but the EPS beat indicates effective cost management. The management's cautious optimism suggests they are focused on maintaining performance while navigating market challenges.","metaDescription":"Boston Scientific (BSX) Q4 2016 earnings: EPS beat by 4.9%. Stock up 4.76%. Full breakdown."}}